NL170141C - PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH ACTION ON THE CENTRAL NERVOUS SYSTEM BASED ON HYDROGENATED 3-SUBSTITUTE-BENZOIC-QUINOLINE DERIVATIVES, AND PROCESS FOR PREPARING HYDROGENATED 3-SUBSTITUTE-SUBSTITUTE VASE. - Google Patents

PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH ACTION ON THE CENTRAL NERVOUS SYSTEM BASED ON HYDROGENATED 3-SUBSTITUTE-BENZOIC-QUINOLINE DERIVATIVES, AND PROCESS FOR PREPARING HYDROGENATED 3-SUBSTITUTE-SUBSTITUTE VASE.

Info

Publication number
NL170141C
NL170141C NLAANVRAGE7705433,A NL7705433A NL170141C NL 170141 C NL170141 C NL 170141C NL 7705433 A NL7705433 A NL 7705433A NL 170141 C NL170141 C NL 170141C
Authority
NL
Netherlands
Prior art keywords
substitute
hydrogenated
preparation
vase
benzoic
Prior art date
Application number
NLAANVRAGE7705433,A
Other languages
Dutch (nl)
Other versions
NL7705433A (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL7705433A publication Critical patent/NL7705433A/en
Application granted granted Critical
Publication of NL170141C publication Critical patent/NL170141C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1782—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
    • C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NLAANVRAGE7705433,A 1976-05-17 1977-05-17 PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH ACTION ON THE CENTRAL NERVOUS SYSTEM BASED ON HYDROGENATED 3-SUBSTITUTE-BENZOIC-QUINOLINE DERIVATIVES, AND PROCESS FOR PREPARING HYDROGENATED 3-SUBSTITUTE-SUBSTITUTE VASE. NL170141C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68733276A 1976-05-17 1976-05-17
US75361976A 1976-12-22 1976-12-22
US77792877A 1977-03-15 1977-03-15

Publications (2)

Publication Number Publication Date
NL7705433A NL7705433A (en) 1977-11-21
NL170141C true NL170141C (en) 1982-10-01

Family

ID=27418484

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE7705433,A NL170141C (en) 1976-05-17 1977-05-17 PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH ACTION ON THE CENTRAL NERVOUS SYSTEM BASED ON HYDROGENATED 3-SUBSTITUTE-BENZOIC-QUINOLINE DERIVATIVES, AND PROCESS FOR PREPARING HYDROGENATED 3-SUBSTITUTE-SUBSTITUTE VASE.
NL7804461A NL7804461A (en) 1976-05-17 1978-04-26 PROCESS FOR THE PREPARATION OF NEW BENZO / C / CHINOLINS.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL7804461A NL7804461A (en) 1976-05-17 1978-04-26 PROCESS FOR THE PREPARATION OF NEW BENZO / C / CHINOLINS.

Country Status (23)

Country Link
JP (1) JPS6016426B2 (en)
AR (1) AR215896A1 (en)
BG (4) BG28415A4 (en)
CA (1) CA1095909A (en)
CH (2) CH626881A5 (en)
DD (1) DD130855A5 (en)
DE (1) DE2722383A1 (en)
DK (1) DK212677A (en)
ES (4) ES458812A1 (en)
FI (1) FI64141C (en)
FR (2) FR2362129A1 (en)
GR (1) GR74122B (en)
IL (1) IL52087A (en)
LU (1) LU77341A1 (en)
NL (2) NL170141C (en)
NO (1) NO147028C (en)
NZ (1) NZ184114A (en)
PH (1) PH16833A (en)
PT (1) PT66550B (en)
RO (1) RO76839A (en)
SE (1) SE7704749L (en)
SU (1) SU1098520A3 (en)
YU (2) YU156882A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2802211A1 (en) * 1978-01-19 1979-07-26 Basf Ag N-SUBSTITUTED 2,6-DIALKYLANILINES AND METHOD FOR PREPARING N-SUBSTITUTED 2,6-DIALKYLANILINES
US4206225A (en) * 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4228169A (en) * 1979-06-26 1980-10-14 Pfizer Inc. 1,9-Dihydroxyoctahydrobenzo[c]quinolines and 1-hydroxyhexahydrobenzo[c]quinoline-9(8H)-ones as antiemetic agents
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
US4406888A (en) * 1981-01-09 1983-09-27 Pfizer Inc. Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
RU2015144653A (en) 2009-03-25 2018-12-29 Эббви Инк. ANTIVIRAL COMPOUNDS AND THEIR APPLICATIONS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3649650A (en) * 1970-02-13 1972-03-14 Little Inc A Novel derivatives of tetrahydro-cannabinol
CA994791A (en) * 1971-05-12 1976-08-10 Louis S. Harris Esters of benzopyrans
US3856821A (en) * 1973-07-18 1974-12-24 Smithkline Corp ALKOXY DIBENZO (b,d) PYRANS
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US3944673A (en) * 1973-11-05 1976-03-16 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as analgesic drugs
US3968125A (en) * 1973-11-05 1976-07-06 Eli Lilly And Company Dihydroxyhexahydrodibenzo[b,d]pyrans
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor

Also Published As

Publication number Publication date
DE2722383C2 (en) 1990-06-07
GR74122B (en) 1984-06-06
FR2446284A1 (en) 1980-08-08
BG28414A4 (en) 1980-04-15
NO771738L (en) 1977-11-18
PT66550B (en) 1978-10-18
NL7705433A (en) 1977-11-21
FI64141B (en) 1983-06-30
NZ184114A (en) 1982-02-23
SU1098520A3 (en) 1984-06-15
BG27897A3 (en) 1980-01-15
RO76839A (en) 1981-05-30
BG28415A4 (en) 1980-04-15
CH626881A5 (en) 1981-12-15
ES469203A1 (en) 1978-11-16
CH628034A5 (en) 1982-02-15
FR2446284B1 (en) 1983-08-26
JPS52144672A (en) 1977-12-02
ES458812A1 (en) 1978-08-16
FR2362129A1 (en) 1978-03-17
FI771550A (en) 1977-11-18
IL52087A (en) 1981-11-30
YU156982A (en) 1983-02-28
SE7704749L (en) 1977-12-05
FI64141C (en) 1983-10-10
LU77341A1 (en) 1977-12-13
DK212677A (en) 1977-11-18
FR2362129B1 (en) 1983-05-20
JPS6016426B2 (en) 1985-04-25
IL52087A0 (en) 1977-07-31
PH16833A (en) 1984-03-06
DD130855A5 (en) 1978-05-10
PT66550A (en) 1977-06-01
NL7804461A (en) 1978-08-31
BG28416A4 (en) 1980-04-15
DE2722383A1 (en) 1977-12-01
NO147028B (en) 1982-10-11
ES469202A1 (en) 1978-11-16
NO147028C (en) 1983-01-19
AR215896A1 (en) 1979-11-15
YU156882A (en) 1983-02-28
AU2516277A (en) 1978-06-22
CA1095909A (en) 1981-02-17
ES469204A1 (en) 1978-11-16

Similar Documents

Publication Publication Date Title
NL178076C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-BLOOD PRESSURE EFFECT BASED ON QUINAZOLINE DERIVATIVES, AND METHOD FOR PREPARING THE MEDICINAL QUINAZOLINE DERIVATIVES
NL188573C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH HYPOTENSIVE ACTION AND PROCESS FOR PREPARING SUBSTITUTED ANILINOACETAMIDOXIMES.
NL185563B (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING SUBSTITUTE SUBSTITUTED 1-PHENYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES.
NL175415C (en) METHOD FOR PREPARING A HERBICIDE PREPARATION, AND METHOD FOR PREPARING ISOXAZOLE DERIVATIVES WITH HERBICIDE ACTION
NL7706532A (en) PROCESS FOR PREPARING ESTERS WITH ANTI-BACTERIAL ACTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING ESTERS.
NL166945C (en) PROCESS FOR THE PREPARATION OF 3-CARBAMOYL-4-OXO-4H-PYRIMIDO2.1-BŸBENZTHIAZOLES WITH PHARMACOLOGICAL ACTION, PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTI-ALLERGIC ACTION, AND PRODUCTS MANUFACTURED THEREOF.
NL145142B (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH ACTION ON THE NERVOUS SYSTEM, FORMED MEDICINAL PRODUCT, AND METHOD FOR PREPARING SUITABLE MEDICINAL COMPOUNDS.
NL7702369A (en) 4-ANDROSTEEN-3-ONES AND METHOD FOR PREPARING THIS AND METHOD FOR PREPARING A MEDICINAL PRODUCT WITH DIURETIC ACTION.
NL170141C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH ACTION ON THE CENTRAL NERVOUS SYSTEM BASED ON HYDROGENATED 3-SUBSTITUTE-BENZOIC-QUINOLINE DERIVATIVES, AND PROCESS FOR PREPARING HYDROGENATED 3-SUBSTITUTE-SUBSTITUTE VASE.
NL167697C (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION ACTING ON THE CENTRAL NERVOUS SYSTEM BASED ON 5-PHENYLBENZODIAZEPINE DERIVATIVES, AND METHOD FOR PREPARING 5-PHENYLBODODIA ZEPARIC THESE BEFORE USE THEREFORE
NL190267C (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH ANTIBACTERIAL ACTION AND PROCESS FOR PREPARING MEDICINAL OXADETHIA-CEPHALOSPORINE DERIVATIVES.
NL166687C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, ACTING ON THE CENTRAL NERVOUS SYSTEM BASED ON BENZODIAZEPINE DERIVATIVES, AND A METHOD FOR PREPARING THE BENZOIAZEPINE DERIVATIVES USED THEREIN.
NL186315C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANALGETIC AND ANTIHYPER THERMAL ACTION, FORMED MEDICINAL PRODUCT AND METHOD FOR PREPARING A MEDICINAL β-ACETAMIDOPHENOL DERIVATIVE
NL7612894A (en) PROCEDURE FOR THE PREPARATION OF HETEROCYCLIC COMPOUNDS ACTING ON THE CENTRAL NERVOUS SYSTEM, PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH ACTION AND MEDICINAL PRODUCT.
NL154923B (en) PROCESS FOR PREPARING A RECAPTERATION AND THE REAPERATION PREPARED WITH THIS PROCEDURE.
NL161455C (en) PROCESS FOR PREPARING A PREPARATION WITH ACARICIDE ACTION, AND PROCESS FOR PREPARING QUATERARY SALTS OF BICYCLIC THIAZOLIC DERIVATIVES.
NL165736B (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH AN ACTION ON THE CENTRAL NERVOUS SYSTEM AND THE CARDIO-VASCULAR SYSTEM AND WITH AN ANTI-INFLAMMATIC ADRENOLYTIC AND ANTI-ULCER PREPARATELY PREPARED PRODUCTION. -2-ONES.
NL7604882A (en) PROCEDURE FOR THE PREPARATION OF BICYCLOOCTA DERIVATIVES ACTING ON THE CENTRAL NERVOUS SYSTEM, PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH ACTION AND OF ANY MEDICINAL PRODUCT.
NL7704218A (en) CORTICOIDES, METHOD FOR PREPARING THEREOF, AND METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY ACTION.
NL7705839A (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT AGAINST EYE DISEASES AND THE MEDICINAL PRODUCT THEREFORE.
NL7609662A (en) PROCESS FOR PREPARING 14-PLACE SUBSTITUTED VINCAAN DERIVATIVES AND PROCEDURE FOR PREPARING A MEDICINAL PRODUCT WITH VASO-ACTIVE AND SPASMOLYTIC ACTION.
NL7412346A (en) PROCEDURE FOR PREPARING A PREPARATION WITH ANALGETIC AND ANALGETIC ACTION.
NL7714054A (en) BASICLY SUBSTITUTED O-PROPYLOXIMES, PROCESS FOR THE PREPARATION THEREOF, AND PROCESS FOR PREPARING A MEDICINE WITH BLOOD PRESSURE-REDUCING ACTION.
NL7713595A (en) CORTICOIDES, METHOD FOR PREPARING THEREOF AND METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-PHOGISTICAL ACTION.
NL7713642A (en) PROCESS FOR PREPARING NEW PHENYLPI-PERAZINE DERIVATIVES WITH SOOTHING ACTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS.